Infectious Disease

FAQs address Cyclospora recovery, high-risk populations, antibiotic use, C. difficile risk, and CDC/FDA outbreak response.

June 2026 brought 5 FDA firsts across infectious disease, oncology, and rare disease, expanding treatment options and addressing unmet patient needs.

New York City health officials confirmed a 5th fatality in the Upper East Side Legionnaires' disease outbreak.

KFF poll links social media use and not having a trusted doctor to vaccine myth beliefs, fueling COVID-19 and measles risk.

New Legionnaires disease cases in NYC's Upper East Side cluster have declined as officials continue cooling tower remediation and investigation.

Michigan has confirmed more than 1500 cyclospora cases as officials investigate the source of one of the nation's largest foodborne parasite outbreaks.

Ebola cases hit 1708 as unpaid health workers strike, further straining an outbreak response the World Health Organization says is outpacing containment.

The FDA advisory committee supports Moderna’s mRNA-1010 flu vaccine for adults 50-plus, with an August 5 PDUFA decision pending for mFlusiva.

National HIV Testing Day highlights how state policies, pharmacists, and long-acting therapies are reshaping access to HIV testing, PrEP, and PEP.

The move follows the close of a 42-day quarantine for American cruise-ship passengers exposed to the rare Andes strain.

FDA approval of generic rifapentine introduces a new option for treating active tuberculosis and preventing progression of latent infection.

The FDA approved the first oral carbapenem, tebipenem pivoxil, for complicated UTIs, offering an alternative to intravenous therapy.

Distrust, misinformation, and conflict complicate Ebola response efforts in the DRC, highlighting broader challenges to public health trust.

Despite increases in influenza vaccine rates before the pandemic in the Bronx, rates have decreased between 2020 and 2023.

As quarantined cruise passengers return home, experts explain Andes hantavirus symptoms, transmission risks, and prevention.

Children aged 2 to 5 years with fall birthdays had higher flu vaccination rates and fewer diagnoses than those with summer birthdays.

The Ugandan MInistry of Health closed their border with the DRC in response to the rise in Bundibugyo cases and deaths.

Eighteen Legionella cases were linked to Kaiser Santa Clara as officials investigate the source and infection risks.

A rare hantavirus outbreak aboard a cruise ship has killed 3 passengers, raising concerns over Andes virus transmission risks.

RSV vaccines and nirsevimab are linked to reduced infant hospitalizations, though seasonal spikes and data limitations remain concerns.

ACIP changes threaten vaccine coverage and raise costs, according to a roundtable of experts warning of widening disparities and long-term public health risks.

The US has seen approximately 370 cases of mpox through March 2026, indicating a consistent need to diagnose the illness.

A federal court blocked RFK Jr's vaccine agenda, freezing the ACIP shakeup and safeguarding child vaccine access as the legal fight over vaccines intensifies.

The politicization of public health is eroding vaccine confidence, risking lower uptake and potential disease outbreaks, says Noel T. Brewer, PhD.

Noel T. Brewer, PhD, former ACIP member, warns that the CDC's reduction from 17 to 11 recommended immunizations lacks transparency, which may lower uptake.